Ticagrelor Market Is Estimated To Witness High Growth Owing To Increasing Prevalence Of Coronary Artery Disease

Poonam

Ticagrelor Market Is Estimated To Witness High Growth Owing To Increasing Prevalence Of Coronary Artery Disease

Ticagrelor is an oral antiplatelet drug that works by blocking the action of platelets and reduces the risk of blood clots forming or growing bigger within the coronary arteries. Ticagrelor is used in patients with acute coronary syndromes or myocardial infarction with ST-segment elevation. Ticagrelor helps prevent fatal or non-fatal heart attacks or strokes.

The global ticagrelor market is estimated to be valued at US$ 1285.83 million in 2023 and is expected to exhibit a CAGR of 3.3% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.

Market Opportunity

The increasing prevalence of coronary artery disease across the globe represents a major growth opportunity for the ticagrelor market. Coronary artery disease remains the leading cause of mortality worldwide. As per estimations, over 18 million people die from cardiovascular diseases globally every year. Further, high adoption of unhealthy lifestyle choices like smoking, excessive alcohol consumption, physical inactivity, and unhealthy diet have contributed to the rising burden of coronary artery disease. As ticagrelor is extensively used for treatment of patients with acute coronary syndromes and myocardial infarction, high disease prevalence is likely to propel the demand for ticagrelor over the forecast period.

Porter's Analysis

Threat of new entrants: The ticagrelor market has moderate threat of new entrants due to the requirement of high R&D investment and clinical trials for new drug development.

Bargaining power of buyers: The bargaining power of buyers is moderate as ticagrelor is not the only drug available for treatment of indications like myocardial infarction and stroke.

Bargaining power of suppliers: The bargaining power of suppliers is moderate as there are many manufacturers supplying active pharmaceutical ingredients (APIs) and other raw materials for ticagrelor production.

Threat of new substitutes: The threat of new substitutes is moderate as newer antiplatelets and anticoagulants are being researched but ticagrelor still maintains its position in treatment guidelines.

Competitive rivalry: The competitive rivalry is high among the major players operating in the ticagrelor market.

SWOT Analysis

Strengths: High efficacy and safety profile of ticagrelor for treatment of myocardial infarction and prevention of stroke. Established market presence with patents protection till 2023-2024.

Weaknesses: High manufacturing cost of ticagrelor. Risk of bleeding due to antiplatelet effect. Requires compliance for effectiveness.

Opportunities: Growth opportunities in developing countries. Increasing research for new formulations and combinational therapies.

Threats: Patent expiry of branded ticagrelor between 2023-2024 enabling generic competition. Stringent regulations for drug approval.

Key Takeaways

The global Ticagrelor Market Growth is expected to witness high growth over the forecast period of 2023-2030 driven by rising prevalence of cardiovascular diseases. The global ticagrelor market is estimated to be valued at US$ 1285.83 million in 2023 and is expected to exhibit a CAGR of 3.3% over the forecast period 2023-2030.

Regional analysis shows that North America will continue dominating the ticagrelor market during the forecast period supported by rising healthcare spending and growing demand for advanced antiplatelet therapies. Asia Pacific is poised to be the fastest growing regional market attributed to increasing cases of myocardial infarction and large patient pool.

Key players operating in the ticagrelor market are ANDRITZ Group, Baltur S.p.A, Bloom Engineering, Wood Group PLC, Honeywell International Inc., Limpsfield Combustion Engineering Ltd, Mitsubishi Hitachi Power Systems, Ltd, Oilon Group, Osaka Gas Co., Ltd, Selas Heat Technology Company, R.W. Beckett Corp, SAACKE GmbH, Industrial Combustion IC, Wesman Group, Striko Westofen, Forbes Marshall Pvt. Ltd., QED Combustion, Alzeta Corporation, Alfa Therm Limited, Weishaupt, Enertech GmbH, Power Flame, EOGB Energy Products Ltd., Babcock Wanson, Riello S.p.A, Zeeco, Inc., Alfa Laval, Corbett Industries, Inc., Faber Burner Company, AGF Burner Inc., John Zink Hamworthy Combustion, Oxilon Private Limited, Wayne Combustion Systems, SECO/WARWICK, INC., Surface Combustion, Inc., Midco International,

For more insights, read- https://www.newsanalyticspro.com/ticagrelor-market-trends-size-and-share-analysis/

Poonam

Ticagrelor Market Is Anticipated To Witness High Growth Owing To Increasing Prevalence Of Cardiovascular Diseases

Pratik 2024-03-13

The global ticagrelor market is estimated to be valued at US$ 1481. Key TakeawaysKey players operating in the Ticagrelor Market Demand are Atlas Roofing Corporation, BASF SE, Johns Manville, Duro-Last, Inc. Growing prevalence of cardiovascular diseases and increasing demand for effective antiplatelet drugs post procedures such as angioplasty and stenting are expected to create significant growth opportunities for players in the global ticagrelor market. Growing burden of diseases like diabetes and obesity which are contributors to cardiovascular conditions is anticipated to propel the demand for antiplatelet drugs like ticagrelor over the forecast period. This large patient pool and enhanced efficacy over alternatives drives the growth of the ACS sub segment of the ticagrelor market.

Ticagrelor An Antiplatelet Drug Is Fueling Growth Of The Global Ticagrelor Market

samruddhicmi12 2023-12-07

The Global Ticagrelor Market is estimated to be valued at US$ 1285. According to World Health Organization, cardiovascular diseases are the leading cause of death globally, taking an estimate of over 17. Segment AnalysisThe global ticagrelor market is segmented by dosage, application, distribution channel, and region. Geographically, North America holds the largest share in the ticagrelor market due to growing initiatives by healthcare organizations to spread awareness regarding antiplatelet treatment options. AstraZeneca's Brilinta is the leading brand in the global ticagrelor market.

Ticagrelor Market connected with Global CAGR trends outline as a part of heading

Leena Shedmake 2023-10-27

The global Ticagrelor Market is estimated to be valued at US$ 2,400. Porter's Analysis Threat of new entrants: The ticagrelor market requires high investments for R&D and manufacturing. Competitive rivalry: The ticagrelor market is consolidated with key players like Pfizer and AstraZeneca having major market share. Key Takeaways The Global Ticagrelor Market Demand is expected to witness high growth, exhibiting CAGR of 12. Pfizer leads the global ticagrelor market with its brand Brilinta, while AstraZeneca also has a major share.

The Global Ticagrelor Market Growth Accelerated By Increasing Prevalence Of Cardiovascular Disorders

Mia Yates 2024-01-24

The Global Ticagrelor Market Size is estimated to be valued at US$ 1481. This has significantly contributed to the growth of the ticagrelor market over the forecast period. Segment Analysis The global ticagrelor market is dominated by the hospital pharmacy sub-segment. Regional analysis North America currently dominates the ticagrelor market and is expected to continue its leading position through 2031. Additionally, favorable reimbursement environment for novel drugs in the US and Canada is boosting market growth.

In People With A History Of Heart Disease, Ticagrelor, Along With Low-Dose Aspirin, Is Used To Prevent Heart Attacks And Strokes

Pooja salve 2023-04-03

It has a moderate duration of action because it is used twice day, and it has a broad therapeutic index because high single doses are easily tolerated. It has a half-life of approximately 7 hours, which means that it is cleared from the body relatively quickly. In the PLATO trial, which compared ticagrelor to clopidogrel in over 18,000 patients with ACS, ticagrelor was found to be superior in reducing the incidence of cardiovascular death, heart attack, and stroke. Like all medications, ticagrelor can cause side effects. The most common side effects of ticagrelor include bleeding, shortness of breath, and nausea.

Animal Healthcare Market Is Estimated To Witness High Growth Owing To Opportunity For Preventing Spread Of Zoonotic Diseases

Poonam 2023-12-29

The global Animal Healthcare Market is estimated to be valued at US$ 50. Porter's Analysis Threat of new entrants: The animal healthcare market requires high R&D investments and regulatory approvals for new products. Their bargaining power is moderate as there are many established manufacturers offering a variety of animal healthcare products. Key Takeaways The global Animal Healthcare Market Growth is expected to witness high growth during the forecast period of 2023 to 2030 backed by increasing pet ownership and growing meat consumption. Key players related content: Key players operating in the animal healthcare market are Low & Bonar PLC, Ahlstrom Group, E.

WHO TO FOLLOW